The study was conducted under a case control design in 405 eligible matched pairs from May 2001 to September 2005 at four hospitals in Nagano Prefecture, Japan.
A total of 276 eligible matching controls were identified.
In many cases, therefore, a given mouse i would have multiple eligible matches.
If more than one control met matching criteria for a single case, control selection among eligible matches was made randomly.
Eligible matches were found for each sampling unit through 2 digit suffixes generated from random number tables [ 2].
The G2P[4] genotype accounted for 52% of cases confirmed by polymerase chain reaction with eligible matched controls.
Figure 4 shows the distribution of the percent of short-spaced births with eligible matches for all 145 surveys in our analysis.
Results Based on 33 IPD meta-analyses and 177 eligible, matched clinical guidelines there was evidence that IPD meta-analyses were being under-utilised.
In 25% of cases confirmed by polymerase chain reaction with eligible matched controls, there was reported co-infection with adenovirus, astrovirus and/or norovirus.
To assess the temporal relationship between α antagonist initiation and our primary outcomes, we repeated our analysis among eligible matched men 180 days before their first initiation of α antagonists.
